Location
United States, North America
Cheque size
$2.5M - $60M
Investment Stage
Seed
Series A
Series B
Focus Areas
BioTech
About Investor
Scott Biller is an Executive Venture Partner at GV with a primary focus on Biotechnology investments. He supports Seed through Series B companies developing innovative therapeutics and life sciences technologies. Scott brings extensive healthcare operating and investment experience to portfolio companies. He advises founders on clinical development, commercialization, and strategic growth. His investment interests include biotechnology, precision medicine, and healthcare innovation. His investment approach combines scientific rigor with long-term value creation.
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,FB
Frank Balas
Canada, North America
$100K - $5M
Pre Seed
,Seed
,FF
Faraz Fatemi
United States, North America
$1M - $30M
Seed
,Series A
,VL
Vishal Lugani
United States, North America
$700K - $7M
Seed
,Series A
,AM
Alex Moore
United States, North America
$3M - $30M
Seed
,Is this Your Profile?
If you have any updates, please fill out our form.